We are live on ! Find out more
EWA

EverSource Wealth Advisors Portfolio holdings

AUM $2.97B
1-Year Est. Return 28.74%
This Fund
S&P 500
This Quarter Est. Return
+8.52%
1 Year Est. Return
+28.74%
3 Year Est. Return
+89.7%
5 Year Est. Return
10 Year Est. Return
AUM
$2.53B
AUM Growth
+$313M
Cap. Flow
+$148M
Cap. Flow %
5.84%
Top 10 Hldgs %
19.9%
Holding
4,514
New
265
Increased
1,954
Reduced
1,603
Closed
193

Sector Composition

Rank Sector Weight
1 Technology 12.84%
2 Financials 7.69%
3 Consumer Discretionary 5.5%
4 Industrials 3.53%
5 Communication Services 3.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RANI icon
3951
Rani Therapeutics
RANI
$90.4M
$490 ﹤0.01%
+980
New +$511
LCTX icon
3952
Lineage Cell Therapeutics
LCTX
$259M
$487 ﹤0.01%
288
-714
-71% -$845
NN icon
3953
NextNav
NN
$1.74B
$487 ﹤0.01%
34
-72
-68% -$1.14K
CNTA
3954
DELISTED
Centessa Pharmaceuticals
CNTA
$485 ﹤0.01%
20
INR
3955
Infinity Natural Resources
INR
$252M
$485 ﹤0.01%
37
-344
-90% -$4.93K
BHC icon
3956
Bausch Health
BHC
$1.68B
$484 ﹤0.01%
75
MERC icon
3957
Mercer International
MERC
$45M
$484 ﹤0.01%
168
-275
-62% -$907
WWR icon
3958
Westwater Resources
WWR
$50.8M
$474 ﹤0.01%
500
OMER icon
3959
Omeros
OMER
$817M
$472 ﹤0.01%
115
-68
-37% -$270
ACTU
3960
Actuate Therapeutics
ACTU
$27M
$469 ﹤0.01%
+70
New +$507
VMEO
3961
DELISTED
Vimeo
VMEO
$465 ﹤0.01%
60
-569
-90% -$2.8K
MLNK
3962
DELISTED
MeridianLink
MLNK
$458 ﹤0.01%
23
-404
-95% -$7.43K
NVCT icon
3963
Nuvectis Pharma
NVCT
$616M
$458 ﹤0.01%
76
-20
-21% -$137
ARTV
3964
Artiva Biotherapeutics
ARTV
$504M
$456 ﹤0.01%
+159
New +$425
CSTL icon
3965
Castle Biosciences
CSTL
$736M
$455 ﹤0.01%
20
-27
-57% -$548
FUN icon
3966
Cedar Fair
FUN
$1.8B
$454 ﹤0.01%
20
-313
-94% -$8.31K
JACK icon
3967
Jack in the Box
JACK
$300M
$454 ﹤0.01%
23
-72
-76% -$1.43K
ANIK icon
3968
Anika Therapeutics
ANIK
$200M
$451 ﹤0.01%
48
-64
-57% -$611
AOMR
3969
Angel Oak Mortgage REIT
AOMR
$222M
$450 ﹤0.01%
48
+40
+500% +$383
CLYM
3970
Climb Bio
CLYM
$735M
$450 ﹤0.01%
224
+173
+339% +$321
LFCR icon
3971
Lifecore Biomedical
LFCR
$162M
$449 ﹤0.01%
61
+7
+13% +$53
TVGN icon
3972
Tevogen Bio Holdings
TVGN
$22.7M
$447 ﹤0.01%
11
+9
+450% +$443
TLSI icon
3973
TriSalus Life Sciences
TLSI
$265M
$446 ﹤0.01%
+96
New +$449
ALTI icon
3974
AlTi Global
ALTI
$395M
$445 ﹤0.01%
125
+6
+5% +$25
UNTY icon
3975
Unity Bancorp
UNTY
$585M
$440 ﹤0.01%
9
-119
-93% -$6.05K

Similar funds

EverSource Wealth Advisors's Q3 2025 Portfolio in Review

As of Q3 2025, EverSource Wealth Advisors held 4,514 positions worth $2.53B, up 14% from $2.21B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

EverSource Wealth Advisors deployed $148M of net new capital in Q3 2025, opening 265 new positions and adding to 1,954 existing holdings. Its largest new stake was PGIM Short Duration High Yield ETF: 116,681 shares worth $5.93M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Graphic Packaging, an estimated $6.83M trimmed.

  • EverSource Wealth Advisors's largest Q3 2025 buy was PGIM Short Duration High Yield ETF: 116,681 shares worth $5.93M.
  • EverSource Wealth Advisors added most to Apollo Global Management in Q3 2025, an estimated $28.3M increase.
  • EverSource Wealth Advisors's biggest Q3 2025 reduction was Graphic Packaging, cutting an estimated $6.83M.
  • EverSource Wealth Advisors fully exited Bridge Investment Group in Q3 2025, selling an estimated $2.99M.
  • EverSource Wealth Advisors's ten largest holdings make up 20% of its $2.53B portfolio in Q3 2025.
  • EverSource Wealth Advisors opened 265 new positions and closed 193 in Q3 2025.
  • EverSource Wealth Advisors's portfolio value rose 14% quarter-over-quarter to $2.53B.

Based on EverSource Wealth Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.